Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:18 PM
Ignite Modification Date:
2025-12-24 @ 9:18 PM
NCT ID:
NCT05324904
Eligibility Criteria:
Inclusion Criteria:
* Adult participants of both sex with plantar warts will be included in the study
Exclusion Criteria:
* \- Children \< 12 years.
* Pregnant and lactating women.
* Receiving any treatment for warts within 1 month before the study.
* Systemic antiviral medication.
* Previous history of vitamin D or acyclovir hypersensitivity.
* Vitamin D supplementation.
* Concurrent other skin disorders.
* Immunosuppressive disorders or receiving immunosuppressive drugs.
* Receiving drugs that may alter vitamin D level including prednisone, orlistat, phenytoin and thiazide diuretics.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
12 Years
Maximum Age:
70 Years
Study:
NCT05324904
Study Brief:
Protocol Section:
NCT05324904